A new association announces a revolution in the treatment of ovarian cancer
In ovarian cancer, the combination of a PARP inhibitor and an inhibitor of BRDA4, a small regulatory molecule, is effective ...
Read moreIn ovarian cancer, the combination of a PARP inhibitor and an inhibitor of BRDA4, a small regulatory molecule, is effective ...
Read more